Breast cancer is the most common non-cutaneous cancer in women, and the second most frequent cause of cancer death among women. 1 Approximately 50% of breast cancer cases are estrogen receptor ...
Current use of ROS1 testing in clinical practice in the United States, France, Germany, Italy, and Japan. Discordance between Magee and ODX-RS scores.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results